Brian Locke
Intensivist attending at Intermountain, specializing in pulmonary care and clinical investigation. Experienced in statistics and research design.
Best podcasts with Brian Locke
Ranked by the Snipd community
5 snips
Mar 27, 2025 • 1h 33min
Half Dose DOAC for Long Term VTE Prevention, Biomarker Guided Antibiotics for Sepsis, GPT-4 Assistance for Physicians, Optimal Vasopressin Initiation for Shock, DOAC vs No AC for A fib After Intracerebral Hemorrhage, HFNC vs NIV for Respiratory Failure
Join Dr. Brian Locke, an intensivist at Intermountain with a knack for statistics, as he dives into cutting-edge medical research. He discusses the effectiveness of half-dose DOACs for VTE prevention, weighing bleeding risks and treatment options. The conversation heats up around using biomarkers to guide antibiotic durations for sepsis, alongside the challenges and promises of AI, particularly GPT-4, in enhancing physician productivity. Additionally, Locke examines critical decisions around anticoagulation in atrial fibrillation and compares high-flow nasal cannula versus non-invasive ventilation for respiratory failure.
Jun 27, 2023 • 59min
Metformin and Long COVID, Central Lines and Thrombocytopenia, DOACs vs LMWH in Cancer Associated Thrombosis, Early vs Late Anticoagulation after Stroke with Atrial Fibrillation
Dr. Brian Locke, a recently graduated pulmonary-critical care fellow, discusses interesting topics such as the potential of metformin in reducing long COVID, platelet transfusion before central line placement, the impact of DOACs versus LMWH in cancer-associated thrombosis, and the debate on early versus late anticoagulation after stroke with atrial fibrillation.
